<DOC>
	<DOCNO>NCT00862004</DOCNO>
	<brief_summary>The purpose study examine feasibility video-assisted thoracoscopic surgery ( VATS ) major pulmonary resection systematic node dissection ( SND ) clinical stage IIIA non-small cell lung cancer . Success define VATS major pulmonary resection SND without conversion . If success rate 90 % , VATS major pulmonary resection SND consider feasible procedure clinical stage IIIA non-small cell lung cancer .</brief_summary>
	<brief_title>Video-assisted Thoracoscopic Surgery Stage IIIA Non-Small Cell Lung Cancer</brief_title>
	<detailed_description>Video-assisted minimally invasive surgery become standard approach many abdominal surgical operation cholecystectomy fundoplication . With respect thorax , video-assisted thoracoscopic surgery ( VATS ) accept technique biopsy lung pleura surgical treatment pneumothorax . A VATS lobectomy systematic node dissection ( SND ) non-small cell lung cancer ( NSCLC ) gradually introduce many thoracic surgeon since first perform 1995 McKenna associate . They report survival rate stage I lung cancer similar lobectomy do VATS thoracotomy . Although minimally invasive surgery certainly sound good , problematic decrease patient 's safety oncological treatment 's effect . Hence , feasibility safety SND VATS remain controversial . In many institution , indication VATS major pulmonary resection limit clinical stage I II . For application procedure clinical stage IIIA , remain controversial . Recently , Watanabe et al . retrospective study aim determine outcome patient cN0-pN2 NSCLC underwent VATS major pulmonary resection SND versus outcome major pulmonary resection SND open thoracotomy . It demonstrate VATS major pulmonary resection SND feasible approach management cN0-pN2 NSCLC without loss curability . It unnecessary convert VATS approach thoracotomy order SND even pN2 disease reveal VATS major pulmonary resection . The purpose study know whether VATS major pulmonary resection SND clinical stage IIIA non-small cell lung cancer possible .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>Histologically confirm nonsmall cell lung cancer ( Squamous , adenosquamous , large cell , poorly differentiate ) Stage IIIA ( T13 , N2 , M0 ) : N2 disease confirm follow : Mediastinoscopy ; Bronchoscopy fineneedle aspiration esophagoscopy ; PET scan ECOG performance status 01 Hematopoietic : WBC least 4,000/mm^3 ; Platelet count least 100,000/mm^3 Hepatic : Bilirubin normal ; AST/ALT great 1.5 time upper limit normal ( ULN ) ; Alkaline phosphatase great 2.5 time ULN Renal : Creatinine clearance great 60 ml/min Cardiovascular : Cardiac function normal Severe complication infection Pregnant breastfeed woman Clinically significant heart disease Uncontrolled hepatitis , chronic liver disease , diabetes mellitus Another active cancer except properly treat carcinoma situ cervix basal/squamous cell skin carcinoma</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>video-assisted thoracoscopic surgery ( VATS )</keyword>
	<keyword>systematic node dissection ( SND )</keyword>
	<keyword>stage IIIA non-small cell lung cancer</keyword>
</DOC>